Merck & Co.
US-based global pharmaceutical company (known as MSD outside the US and Canada), pairing an enterprise-scale generative-AI deployment with targeted AI drug-discovery collaborations.
- Company type
- Global pharmaceutical company
- Headquarters
- Rahway, United States
- Website
- https://www.merck.com
- Profile last verified
- 2026-07-29
AI Partnerships & Deployments
- 2026-04-22 — Enterprise agentic-AI partnership with Google Cloud (Google Cloud (Gemini Enterprise)). Merck & Co. struck an enterprise partnership with Google Cloud to deploy Gemini and agentic AI across its operations, from drug development to corporate functions. Fierce Pharma reported the deal is worth up to $1 billion. Disclosed: Up to $1B (per Fierce Pharma). Source: Fierce Pharma (accessed 2026-07-29)
- 2025-09-23 — Generative-AI drug discovery collaboration with Variational AI (Variational AI). Merck & Co. entered a collaboration with Variational AI to apply its generative-AI platform to the discovery of small-molecule candidates against hard-to-drug targets. The company release describes potential milestone payments to Variational AI. Disclosed: Up to $349M in potential milestones (per company release). Source: Business Wire (Variational AI release) (accessed 2026-07-29)